Equity MRK
Friday, September 21, 2018   
Adani Ports  362.00    (-2.94%)
 
Asian Paints  1303.10    (1.07%)
 
Axis Bank  599.40    (-1.61%)
 
Bajaj Auto  2795.65    (0.01%)
 
Bharti Airtel  372.40    (0.73%)
 
Coal India  275.65    (-1.75%)
 
H D F C  1835.25    (0.22%)
 
HDFC Bank  1968.85    (0.35%)
 
Hero Motocorp  3165.70    (0.74%)
 
Hind. Unilever  1621.65    (-1.65%)
 
ICICI Bank  317.80    (-0.95%)
 
IndusInd Bank  1761.70    (-2.38%)
 
Infosys  706.30    (-1.96%)
 
ITC  303.75    (1.37%)
 
Kotak Mah. Ban...  1179.65    (-3.86%)
 
Larsen & Toubr...  1331.75    (-0.04%)
 
M & M  957.20    (1.05%)
 
Maruti Suzuki  8039.55    (-2.04%)
 
NTPC  167.35    (-1.03%)
 
O N G C  180.10    (1.95%)
 
Power Grid Cor...  200.20    (1.03%)
 
Reliance Inds.  1216.85    (0.54%)
 
St Bk of India  270.05    (-0.50%)
 
Sun Pharma.Ind...  635.50    (-1.82%)
 
Tata Motors  250.20    (-0.99%)
 
Tata Motors-DV...  131.85    (-3.79%)
 
Tata Steel  624.55    (0.66%)
 
TCS  2103.80    (1.30%)
 
Vedanta  229.70    (-0.13%)
 
Wipro  337.35    (1.38%)
 
Yes Bank  227.05    (-28.71%)
 
Market Menu
plusminDaily Market Tracker
plusminNews
Corporate Information
Corporate Actions
Other Markets
Close
You are here : Equity | News | Corporate News
Cadila Healthcare's JV facility of Zydus Hopsira Oncology receives EIR from USFDA
(13:08, 12 Jul 2018)
Cadila Healthcare announced that the manufacturing facility of Zydus Hopsira Oncology, a 50:50 joint venture company between Zydus Cadila and Hospira Inc., USA (now part of Pfizer Group) at Ahmedabad has received an Establishment Inspection Report (EIR) from the USFDA which concluded that the inspection is closed and states that theinspection classification of this facility is 'Voluntary Action Indicated' (VAI). The manufacturing plant had completed the USFDA audit from 5 to 12 April, 2018.

Powered by Capital Market - Live News